G

Genpharmasec Ltd

GENPHARMA
Market snapshot · 2026-08-11 05:47 UTC

1.05

₹0.00 (+0.00%)

MARKET CAP

₹58.14 Cr

STOCK P/E

105.0x

52W HIGH

₹2.15

52W LOW

₹0.76

BOOK VALUE

₹1.08

EPS

₹0.01

ROE

0.86%

SECTOR

Industrials

DEBT/EQUITY

53.24

VOLUME

65,446

P/B RATIO

0.97x

PEG RATIO

Sector

Industrials

Themes

Commodities Trading
₹2.06₹1.76₹1.45₹1.15₹0.84VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 50.5% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -1.23). Confidence: 57%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Undervalued

5Y Average

240.89

Current

105.00

Overvalued

264.00

Undervalued

157.25

EV/EBITDA
Strongly Undervalued

5Y Average

132.66

Current

72.49

Overvalued

157.12

Undervalued

111.16

P/S
Strongly Undervalued

5Y Average

0.97

Current

0.42

Overvalued

1.12

Undervalued

0.83

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹52 CrMar 2026

Latest net profit

₹2.32 CrMar 2026

Latest EPS

₹0.04Mar 2026

Net margin

3.1%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-10.0%-5.0%0.0%5.0%10.0%-20 Cr0.00 Cr20 Cr40 Cr60 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr15 Cr30 Cr45 Cr60 Cr₹0₹0₹0₹0₹0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit0.00 Cr15 Cr30 Cr45 Cr60 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-40 Cr0.00 Cr40 Cr80 Cr120 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +6.225.967.866.3810.205.305.778.3413.5612.1131.5636.0151.66
Expenses +6.015.947.896.3710.045.075.527.4014.5611.1031.0536.6950.07
Operating Profit0.210.02-0.030.010.160.230.250.94-1.001.010.51-0.681.59
OPM %3.38%0.34%-0.38%0.16%1.57%4.34%4.33%11.27%-7.37%8.34%1.62%-1.89%3.08%
Other Income +0.060.110.150.140.310.580.860.931.060.821.001.431.62
Interest0.060.060.070.120.140.070.040.110.060.080.080.190.25
Depreciation0.010.010.000.000.000.000.040.050.040.040.040.070.09
Profit before tax0.200.060.050.030.330.741.031.71-0.041.711.390.492.87
Tax %-420.00%66.67%80.00%-100.00%115.15%18.92%2.91%35.67%500.00%8.77%41.01%-55.10%19.16%
Net Profit +1.050.030.010.06-0.050.591.001.11-0.231.560.820.762.32
EPS in Rs0.020.000.000.00-0.000.010.020.02-0.000.030.010.010.04
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters +29.98%29.98%29.98%29.98%29.98%
Public +70.02%70.03%70.01%70.02%70.02%
Others0.01%
Jun 2026
Promoters +
Public +

Events Timeline

Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Tuesday, 11Th August, 2026.

Aug 03, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 07, 2026PDFCompany Reports Open

Closure of Trading Window

Jun 26, 2026PDFCompany Reports Open

Compliances-Reg.24(A)-Annual Secretarial Compliance

May 27, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Newspaper Publication

May 23, 2026PDFCompany Reports Open